Macular cystoid spaces in patients with retinal dystrophy

Ophthalmic Genetics

Volumn 37, Issue 4, 2016, Pages 377-383

  Lingao, Michelle D ^a,b   Ganesh, Anuradha ^c   Karthikeyan, Arcot S ^d   Al Zuhaibi, Sana ^c   Al Hosni, Amna ^c   Al Khayat, Aisha ^c   Capasso, Jenina ^a   Trumler, Anya A ^e   Stroh, Eliza ^f   Al Shekaili, Hilal ^c   Cater, Jacqueline R ^a   Levin, Alex V ^a,g  

^a WILLS EYE HOSPITAL   (United States)

^b Asian Eye Institute   (Philippines)

^c SULTAN QABOOS UNIVERSITY   (Oman)

^d ARAVIND EYE HOSPITAL   (India)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f Cord Blood Registry ^*  (United States)

^g THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Carbonic anhydrase inhibitor; macular cysts; retinal dystrophy

Indexed keywords

ADULT; ARTICLE; CASE STUDY; CENTRAL CORNEAL THICKNESS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENETIC SCREENING; HUMAN; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; PRIORITY JOURNAL; RETINA DYSTROPHY; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; VISUAL ACUITY; ADOLESCENT; CHILD; COMPLICATION; DNA MUTATIONAL ANALYSIS; GENETICS; MACULAR EDEMA; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RETINAL DYSTROPHIES; TOPICAL DRUG ADMINISTRATION;

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; EYE PROTEIN; SULFONAMIDE; THIOPHENE DERIVATIVE;

ACETAZOLAMIDE; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; CARBONIC ANHYDRASE INHIBITORS; CHILD; DNA MUTATIONAL ANALYSIS; EYE PROTEINS; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL DYSTROPHIES; RETROSPECTIVE STUDIES; SULFONAMIDES; THIOPHENES; VISUAL ACUITY;

EID: 84958769811     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2015.1101775     Document Type: Article

References (49)

1. A.Ganesh, E.Stroh, G.J.Manayath, et al. Macular cysts in retinal dystrophy. Curr Opin Ophthalmol 2011;22:332–339.
2. G.A.Fishman, R.J.Anderson, B.L.Lam, et al. Prevalence of foveal lesions in type 1 and type 2 Usher’s syndrome. Arch Ophthalmol 1995;113:770–773.
3. M.A.Genead, G.A.Fishman Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol 2010;128:1146–1150.
4. S.Walia, G.A.Fishman, M.Hajali Prevalence of cystic macular lesions in patients with Usher II syndrome. Eye (Lond) 2009;23:1206–1209.
5. M.A.Genead, G.A.Fishman, J.J.McAnany Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome. Doc Ophthalmol 2010;121:231–240.
6. M.Ghajarnia, M.B.Gorin Acetazolamide in the treatment of X-linked retinoschisis maculopathy. Arch Ophthalmol 2007;125:571–573.
7. M.A.Apushkin, G.A.Fishman Use of dorzolamide for patients with X-linked retinoschisis. Retina 2006;26:741–745.
8. S.Walia, G.A.Fishman, R.S.Molday, et al. Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin. Am J Ophthalmol 2009;147:111–115 e1.
9. F.P.Yang, K.Willyasti, S.W.Leo Topical brinzolamide for foveal schisis in juvenile retinoschisis. J AAPOS 2013;17:225–227.
10. S.Salvatore, G.A.Fishman, M.A.Genead Treatment of cystic macular lesions in hereditary retinal dystrophies. Surv Ophthalmol 2013;58:560–584.
11. H.Hirakawa, H.Iijima, T.Gohdo, et al. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. Am J Ophthalmol 1999;128:185–191.
12. M.A.Apushkin, G.A.Fishman, M.J.Janowicz Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa. Ophthalmology 2004;111:1899–1904.
13. J.Lithander Visual development in healthy eyes from 24 months to four years of age. Acta Ophthalmol Scand 1997;75:275–276.
14. M.A.Genead, G.A.Fishman, S.Walia Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Arch Ophthalmol 2010;128:190–197.
15. J.D.Gass Muller cell cone, an overlooked part of the anatomy of the fovea centralis:hypotheses concerning its role in the pathogenesis of macular hole and foveomacular retinoschisis. Arch Ophthalmol 1999;117:821–823.
16. D.A.Newsome Retinal fluorescein leakage in retinitis pigmentosa. Am J Ophthalmol 1986;101:354–360.
17. S.N.Cox, E.Hay, A.C.Bird Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 1988;106:1190–1195.
18. D.J.Spalton, A.H.Rahi, A.C.Bird Immunological studies in retinitis pigmentosa associated with retinal vascular leakage. Br J Ophthalmol 1978;62:183–187.
19. M.Hajali, G.A.Fishman The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination. Eye (Lond) 2009;23:915–919.
20. S.G.Jacobson, A.V.Cideciyan, A.Sumaroka, et al. Remodeling of the human retina in choroideremia:rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci 2006;47:4113–4120.
21. N.V.Strunnikova, J.Barb, Y.V.Sergeev, et al. Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients. PloS One 2009;4:e8402.
22. E.Rossi, F.Siwiec, C.Y.Yan Pattern of Wnt ligand expression during chick eye development. Braz J Med Biol Res 2007;40:1333–1338.
23. J.Kashef, T.Diana, M.Oelgeschlager, et al. Expression of the tetraspanin family members Tspan3, Tspan4, Tspan5 and Tspan7 during Xenopus laevis embryonic development. Gene Expr Patterns 2013;13:1–11.
24. E.H.Sohn, F.K.Chen, G.S.Rubin, et al. Macular function assessed by microperimetry in patients with enhanced S-cone syndrome. Ophthalmology 2010;117:1199–206 e1.
25. M.A.Genead, G.A.Fishman Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination. Eye (Lond) 2011;25:84–90.
26. C.G.Sauer, A.Gehrig, R.Warneke-Wittstock, et al. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet 1997;17:164–170.
27. U.Tepass, C.Theres, E.Knust crumbs encodes an EGF-like protein expressed on apical membranes of Drosophila epithelial cells and required for organization of epithelia. Cell 1990;61:787–799.
28. J.A.Cordovez, E.I.Traboulsi, J.E.Capasso, et al. Retinal dystrophy with intraretinal cystoid spaces associated with mutations in the crumbs homologue (CRB1) gene. Ophthalmic Genet 2015;36:257–64.
29. S.B.Schwartz, T.S.Aleman, A.V.Cideciyan, et al. Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype. Invest Ophthalmol Vis Sci 2005;46:734–743.
30. D.R.McMillan, K.M.Kayes-Wandover, J.A.Richardson, et al. Very large G protein-coupled receptor-1, the largest known cell surface protein, is highly expressed in the developing central nervous system. J Biol Chem 2002;277:785–792.
31. J.D.Eudy, M.D.Weston, S.Yao, et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science 1998;280:1753–1757.
32. M.D.Weston, J.D.Eudy, S.Fujita, et al. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet 2000;66:1199–1210.
33. P.J.Wistrand, M.Schenholm, G.Lonnerholm Carbonic anhydrase isoenzymes CA I and CA II in the human eye. Invest Ophthalmol Vis Sci 1986;27:419–428.
34. M.F.Marmor, T.Maack Enhancement of retinal adhesion and subretinal fluid resorption by acetazolamide. Invest Ophthalmol Vis Sci 1982;23:121–124.
35. T.J.Wolfensberger, A.V.Dmitriev, V.I.Govardovskii Inhibition of membrane-bound carbonic anhydrase decreases subretinal pH and volume. Doc Ophthalmol 1999;97:261–271.
36. T.M.Wilson, R.Strang, E.T.MacKenzie The response of the choroidal and cerebral circulations to changing arterial PCO2 and acetazolamide in the baboon. Invest Ophthalmol Vis Sci 1977;16:576–580.
37. M.A.Genead, J.J.McAnany, G.A.Fishman Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia. Retina 2012;32:826–833.
38. S.Grover, M.A.Apushkin, G.A.Fishman Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006;141:850–858.
39. A.Thobani, G.A.Fishman The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis. Retina 2011;31:312–315.
40. J.C.Chen, F.W.Fitzke, A.C.Bird Long-term effect of acetazolamide in a patient with retinitis pigmentosa. Invest Ophthalmol Vis Sci 1990;31:1914–1918.
41. G.A.Fishman, L.D.Gilbert, R.G.Fiscella, et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 1989;107:1445–1452.
42. T.J.Ffytche Cystoid maculopathy in retinitis pigmentosa. Trans Ophthalmol Soc UK 1972;92:265–283.
43. R.B.Nussenblatt, S.C.Kaufman, A.G.Palestine, et al. Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology 1987;94:1134–1139.
44. P.E.Stanga, S.M.Downes, R.M.Ahuja, et al. Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies:preliminary results. Int Ophthalmol 2001;23:321–325.
45. A.Gurbaxani, M.Wei, T.Succar, et al. Acetazolamide in retinoschisis:a prospective study. Ophthalmology 2014;121:802–803 e3.
46. Y.J.Kim, S.G.Joe, D.H.Lee, et al. Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa. Invest Ophthalmol Vis Sci 2013;54:1303–1309.
47. N.D.George, J.R.Yates, A.T.Moore Clinical features in affected males with X-linked retinoschisis. Arch Ophthalmol 1996;114:274–280.
48. M.T.Roesch, C.C.Ewing, A.E.Gibson, et al. The natural history of X-linked retinoschisis. Can J Ophthalmol 1998;33:149–158.
49. M.F.Marmor Hypothesis concerning carbonic anhydrase treatment of cystoid macular edema:example with epiretinal membrane. Arch Ophthalmol 1990;108:1524–1525.